Approval · Notice of Compliance 22792 · 2019
IBUPROFEN: Notice of Compliance 22792
Issued October 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22792
- Date
- October 11, 2019
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only